|
Amarin Is A Long-Term Buy With Potential Blockbuster Drug Vascepa Jul. 1, 2019 Summary Amarin is preparing for a monumental label expansion for their flagship product Vascepa with a PDUFA date in September. I have been waiting patiently for an opportunity to buy some cheap shares but the market is not providing me a chance. I am looking for a speculative buy. With an expanded label, Vascepa could be a blockbuster drug that is a mainstay in the cardiac patient paradigm. https://seekingalpha.com/article/4272946-amarin-long-term-bu… |
|
| aus der Diskussion: | Amarin - The Science Of Lipid Therapy |
| Autor (Datum des Eintrages): | bernie55 (01.07.19 17:05:20) |
| Beitrag: | 515 von 1,840 (ID:60929824) |
| Alle Angaben ohne Gewähr © wallstreetONLINE | |